A vaccine has been approved in the war with Corona. DCGI has approved the use of Corbevax as a booster dose. This vaccine has been made by Biological E Ltd.
Vaccine manufacturer Biological E Limited has given information about this approval. Mahima Datla, Managing Director, Biological E Ltd., a Hyderabad-based pharmaceutical and vaccine company, said, “We are very happy with this approval, which will meet the requirement of COVID-19 booster doses in India. We have crossed another milestone in our COVID-19 vaccination journey.”
Recently, Biologicals E Ltd had submitted its trial data to DCGI. After which this approval has been received. These trial data have shown that the Corbevax booster dose is quite effective.
Earlier in April, the DCGI approved Corbevax for emergency use for children aged 5 to 12 years. Till then this vaccine was given to people in the age group of 12-14 years. Recently, Biologicals E reduced the cost of Corbevax from Rs 840 per dose to Rs 250 for private immunization centres. So far, 51.7 million doses of Corbevax have been administered to children in India, of which 17.4 million have been given both doses.
A Corbevax booster may be given six months after the second dose of the vaccine. Till now, the booster dose was essentially the same vaccine given in the first and second shots. Slot can also be booked for this vaccine through Covin. So far this company has supplied 10 crore doses of vaccine to the Centre.
Let us inform that once again the cases of corona have started increasing in some states of the country. According to the data updated by the Union Health Ministry on Saturday, India has registered 3962 new corona cases in the last 24 hours. At the same time 26 people have died.